Yesami Tm News Today

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous/Miscellaneous Relief Reports that its U.S. Collaboration Partner has Announced Progress on Worldwide Commercial Scale Development of ZYESAMI(TM) (aviptadil) 13-Oct-2021 / 07:00 CET/CEST Release of an ad hoc announcemen...

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Study Relief Reports that its U.S. Collaboration Partner has Announced a Positive Safety Report for ZYESAMI(TM) (aviptadil) in NIH Sponsored ACTIV-3 Study in Patients with Life-Threatening COVID-19 19.08.2021 / 07:00   Relief Reports...